NAVIDEA BIOPHARMACEUTICALS, INC. Stock Agreements
25 Contracts & Agreements
- Stock Purchase Agreement dated as of May 22, 2023 between Navidea Biopharmaceuticals, Inc. and Irwin Bain (Filed With SEC on May 25, 2023)
- Stock Purchase Agreement dated as of May 22, 2023 between Navidea Biopharmaceuticals, Inc. and Donald E. Garlikov (Filed With SEC on May 25, 2023)
- Common Stock Purchase Agreement dated as of April 26, 2023 between Navidea Biopharmaceuticals, Inc. and Keystone Capital Partners, LLC (Filed With SEC on April 28, 2023)
- First Amendment to Section 382 Rights Agreement dated as of January 10, 2023 between Navidea Biopharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, LLC (Filed With SEC on January 10, 2023)
- Certificate of Designations, Preferences and Rights of Series I Convertible Preferred Stock (Filed With SEC on August 2, 2022)
- Certificate of Designations, Preferences and Rights of Series I Convertible Preferred Stock (Filed With SEC on July 20, 2022)
- Section 382 Rights Agreement, dated as of April 7, 2022, between Navidea Biopharmaceuticals, Inc. and Continental Stock Transfer & Trust Company, LLC, as Rights Agent (Filed With SEC on April 12, 2022)
- Amendment to Stock Purchase Agreement and Letter of Investment Intent by and between the Company and Investor dated July 8, 2021 (Filed With SEC on July 13, 2021)
- Stock Purchase Agreement and Letter of Investment Intent by and between the Company and Investor dated March 2, 2021 (Filed With SEC on March 4, 2021)
- Form of Common Stock Purchase Agreement (Filed With SEC on September 2, 2020)
- Stock Purchase Agreement and Letter of Investment Intent, by and between the Company and Keystone (Filed With SEC on September 2, 2020)
- Stock Purchase Agreement, effective August 9, 2020, by and between Navidea Biopharmaceuticals, Inc. and Jubilant Radiopharma (Filed With SEC on August 12, 2020)
- Stock Purchase Agreement and Letter of Investment Intent by and between the Company and the Investor (Filed With SEC on May 12, 2020)
- Stock Purchase Agreement, effective February 14, 2020, by and between Navidea Biopharmaceuticals, Inc. and John K. Scott (Filed With SEC on March 18, 2020)
- Stock Purchase Agreement, effective February 14, 2020, by and between Navidea Biopharmaceuticals, Inc. and Keystone Capital Partners, LLC (Filed With SEC on March 18, 2020)
- Stock Purchase Agreement, dated December 6, 2019, among Navidea Biopharmaceuticals, Inc. and the purchasers named therein (Filed With SEC on December 11, 2019)
- Stock Purchase Agreement, dated March 22, 2019, between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr (Filed With SEC on May 9, 2019)
- Stock Purchase Agreement dated September 13, 2018, by and between Navidea Biopharmaceuticals, Inc. and John K. Scott, Jr (Filed With SEC on November 9, 2018)
- NEOPROBECORPORATION CERTIFICATEOF DESIGNATIONS, VOTING POWERS, PREFERENCES,LIMITATIONS, RESTRICTIONS, AND RELATIVE RIGHTSOF SERIES C CONVERTIBLE PREFERRED STOCK (Filed With SEC on June 28, 2010)
- NEOPROBECORPORATION CERTIFICATEOF DESIGNATIONS, VOTING POWERS, PREFERENCES,LIMITATIONS, RESTRICTIONS, AND RELATIVE RIGHTSOF SERIES B CONVERTIBLE PREFERRED STOCK (Filed With SEC on June 28, 2010)
- SERIES AAWARRANT TO PURCHASE SHARES OFCOMMON STOCK OF NEOPROBECORPORATION ExpiresJuly 24, 2014 (Filed With SEC on July 29, 2009)
- NEOPROBECORPORATION SECONDAMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS, VOTINGPOWERS, PREFERENCES, LIMITATIONS, RESTRICTIONS,AND RELATIVE RIGHTS OF SERIES A 8%... (Filed With SEC on July 29, 2009)
- Exhibit4.1 NEOPROBECORPORATION FIRSTAMENDED AND RESTATED CERTIFICATE OF DESIGNATIONS, VOTINGPOWERS, PREFERENCES, LIMITATIONS, RESTRICTIONS,AND RELATIVE RIGHTS OF SERIES A 8%... (Filed With SEC on May 6, 2009)
- FIRST AMENDMENT TO COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on December 31, 2008)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on December 4, 2006)
